Clinical Trials Browser

Neurofibroma, Neurofibromatosis 1, Peripheral Nervous System Neoplasms, Neurofibromatoses, Neurofibroma, Plexiform

NCT02101736 2023-05-24

NF105-CABO

Phase 2 Completed

45 enrolled 10 charts

CNS

Neurofibromatoses, Neurofibroma, Plexiform

NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Phase 1 Completed

20 enrolled 11 charts

CNS

Neurofibromatoses

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Phase 4 Completed

40 enrolled 15 charts

CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

NCT00021541 2018-04-17

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Phase 2 Completed

62 enrolled 13 charts

CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT01140360 2017-07-02

0908-09

Phase 1/2 Completed

21 enrolled 8 charts

CNS

Neurofibroma, Neurofibromatoses

NCT01275586 2017-04-12

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase EARLY_PHASE1 Completed

6 enrolled 7 charts

CNS

Neurofibroma, Neurofibromatoses, Neurofibroma, Plexiform

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

Clinical Trials

NF108-BINI

NF105-CABO

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Dexmedetomidine and Propofol for Pediatric MRI Sedation

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

0908-09

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma